새로운 알츠하이머병 임상진단기준 : NIA-AA 진단가이드라인을 중심으로

키워드

참고문헌 (36)

1. McKhann G, "Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease", Neurology, 34, pp.939~944 (1984)
2. American Psychiatic Association, "Diagnostic and Statistical Manual of Mental Disorders. 4th ed" (1994), American Psychiatric Association
3. World Health Organization, "The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines" (1992), World Health Organization
4. American Psychiatric Association, "Quick reference to the diagnostic criteria from DSM-III" (1980), The Association
5. Varma AR, "Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer’s disease and frontotemporal dementia", J Neurol Neurosurg Psychiatry, 66, pp.184~188 (1999)
6. Kazee AM, "Clinicopathologic correlates in Alzheimer disease: assessment of clinical and pathologic diagnostic criteria", Alzheimer Dis Assoc Disord, 7, pp.152~164 (1993)
7. Neary D, "Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria", Neurology, 51, pp.1546~1554 (1998)
8. McKeith IG, "Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium", Neurology, 65, pp.1863~1872 (2005)
9. Mesulam MM, "Slowly progressive aphasia without generalized dementia", Ann Neurol, 11, pp.592~598 (1982)
10. Benson DF, "Posterior cortical atrophy", Arch Neurol, 45, pp.789~793 (1988)
11. Roman GC, "Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop", Neurology, 43, pp.250~260 (1993)
12. Galton CJ, "Atypical and typical presentations of Alzheimer’s disease: a clinical, neuropsychological, neuroimaging and pathological study of 13 cases", Brain, 3, pp.484~498 (2000)
13. Morris JC, "Mild cognitive impairment is early-stage Alzheimer disease: time to revise diagnostic criteria", Arch Neurol, 63, pp.15~16 (2006)
14. Guillozet AL, "Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment", Arch Neurol, 60, pp.729~736 (2003)
15. Lopez OL, "Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I", Neurology, 55, pp.1854~1862 (2000)
16. Jelic V, "Clinical trials in mild cognitive impairment: lessons for the future", J Neurol Neurosurg Psychiatry, 77, pp.429~438 (2006)
17. Grundman M, "Alzheimer’s Association Research Roundtable Meeting on Mild Cognitive Impairment: what have we learned", Alzheimers Dement, 2, pp.220~233 (2006)
18. Petersen RC, "Vitamin E and donepezil for the treatment of mild cognitive impairment", N Engl J Med, 352, pp.2379~2388 (2005)
19. Thal LJ, "A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment", Neuropsychopharmacology, 30, pp.1204~1215 (2005)
20. Visser PJ, "Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease", J Neurol Neurosurg Psychiatry, 76, pp.1348~1354 (2005)
21. Jicha GA, "Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia", Archives of Neurology, 63, pp.674~681 (2006)
22. Jack CR Jr, "Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia", Neurology, 58, pp.750~757 (2002)
23. Silverman DH, "Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits", J Nucl Med, 43, pp.253~266 (2002)
24. Hulstaert F, "Improved discrimination of AD patients using beta-amyloid (1-42) and tau levels in CSF", Neurology, 52, pp.1555~1562 (1999)
25. Hansson O, "Association between CSF biomarkers and incipient Alzheimer’s disease in patients with mild cognitive impairment: a follow-up study", Lancet Neurology, 5, pp.228~234 (2006)
26. Klunk WE, "Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B", Ann Neurol, 55, pp.306~319 (2004)
27. Shoghi-Jadid K, "Localization of neurofibrillary tangles and beta-amyloid plaques in the brains of living patients with Alzheimer disease", Am J Geriatr Psychiatry, 10, pp.24~35 (2002)
28. Dubois B, "Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria", Lancet Neurol, 6, pp.734~746 (2007)
29. Dubois B, "Revising the definition of Alzheimer’s disease: a new lexicon", Lancet Neurol, 9, pp.1118~1127 (2010)
30. Greig NH, "Editorial: advances in Alzheimer therapy: something old, something new, something borrowed, something blue", Curr Alzheimer Res, 2, pp.275~279 (2005)
31. Herrmann N, "Current and Emerging Drug Treatment Options for Alzheimer’s Disease: A Systematic Review", Drugs, 71, pp.2031~2065 (2011)
32. Cummings JL, "Disease-modifying therapies for Alzheimer disease: challenges to early intervention", Neurology, 69, pp.1622~1634 (2007)
33. Jack CR Jr, "Introduction to the recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.257~262 (2011)
34. McKhann GM, "The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.263~269 (2011)
35. Albert MS, "The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.270~279 (2011)
36. Sperling RA, "Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease", Alzheimers Dement, 7, pp.280~292 (2011)

관련 논문AI추천